Table 2.
Experimental parameters analysis.
| Data Sets | Control group | Risperidone group | Significance | |||
|---|---|---|---|---|---|---|
| n | Mean ± SD | n | Mean ± SD | |||
| AUC (mg/dL·120 min) | 10 | 27,453 ± 2,389 | 10 | 42,276 ± 12,999 | S (P < 0.001) | |
|
| ||||||
| Tissue weight (g) | Liver | 12 | 1.10 ± 0.14 | 12 | 1.50 ± 0.17 | S (P < 0.001) |
|
| ||||||
| Tissue volume (mm3) | Liver | 12 | 635.74 ± 49.54 | 12 | 702.77 ± 32.01 | S (P < 0.01) |
| IAT | 12 | 232.40 ± 34.20 | 12 | 544.19 ± 127.20 | S (P < 0.001) | |
| VAT | 12 | 317.89 ± 116.78 | 12 | 1,065.06 ± 383.76 | S (P < 0.001) | |